Last edition
News about
EazeBio and UC Santa Cruz Partner to Advance Instrument-Free Diagnostic Platform
EazeBio has entered into a strategic partnership with the University of California, Santa Cruz (UC Santa Cruz) to co-develop an innovative cortisol biosensor for stress and metabolic health testing.
PharmaDrug Signs Definitive Agreement to Acquire Equity Interest in Canurta Inc
Under the Definitive Agreement, PharmaDrug will acquire up to a 40 percent equity interest in Canurta, to be completed in two tranches through the issuance of an aggregate of 83,645,316 common shares of PharmaDrug (PHRX Shares) at a deemed price equal to the 20-day volume-weighted average price immediately prior to each closing.
Codexis and Nitto Denko Avecia Partner to Advance Enzymatic Oligonucleotide Manufacturing
Under the agreement, Nitto Denko Avecia will evaluate Codexis’ ECO Synthesis™ Manufacturing Platform, an enzyme-catalysed alternative to traditional solid-phase oligonucleotide synthesis.
FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs
In a new draft guidance, the FDA proposes major updates to simplify biosimilarity studies and reduce unnecessary clinical testing. The agency, through a separate initiative, also plans to make it easier for biosimilars to be developed as interchangeable with brand-name biologics, helping patients and pharmacists choose lower-cost options more easily.
Helex Raises USD 3.5 Million in Seed Round to Advance Non-Viral Gene Therapies for Kidney Diseases
The new funding will support the development of Helex’s lead programme for ADPKD toward IND enabling studies, pipeline expansion leveraging its programmable LNP delivery and AI-based drug design platforms. The company is steadfast in building a robust franchise of renal programmes that profoundly improve and impact the lives of patients.
Novo Nordisk Makes Unsolicited USD 6.5 Billion Bid to Acquire Metsera
Novo Nordisk, a leading global healthcare company founded in 1923 and headquartered in Denmark, has announced that it has submitted an unsolicited proposal to acquire Metsera, Inc.
Siegwerk enters into India's pharma packaging ink segment with mineral oil-free range
Siegwerk has forayed into India’s pharmaceutical packaging segment with the launch of mineral oil-free inks. The new range is designed to enhance consumer safety by preventing ink migration and aims to set new benchmarks for packaging safety in the Indian pharma industry.
Lilly Partners with NVIDIA to Build AI Supercomputer for Drug Discovery and Delivery
Eli Lilly has partnered with NVIDIA to build AI supercomputer, aimed at accelerating the discovery and delivery of new medicines. The collaboration will leverage advanced AI capabilities to identify, optimise, and validate novel molecules, with additional applications in manufacturing, medical imaging, and enterprise AI solutions.
FDA Grants Tentative Approval to Amneal Pharmaceuticals' Generic Version of QVAR Inhalation Aerosol
Beclomethasone dipropionate HFA inhalation aerosol is a corticosteroid indicated for the maintenance treatment of asthma as a prophylactic therapy in patients aged five years and older. It is not indicated for the relief of acute bronchospasm.
FDA Grants Interchangeable Status to Celltrion's Denosumab Biosimilars Stoboclo and Osenvelt
The interchangeability (IC) designation allows Stoboclo and Osenvelt to be substituted at the pharmacy level for their reference biologics without requiring prescriber consultation, in accordance with state pharmacy laws.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy